Clinical Research Directory
Browse clinical research sites, groups, and studies.
Magnetic Seizure Therapy for Psychotic Disorders
Sponsor: Shanghai Jiao Tong University School of Medicine
Summary
This trial aims to evaluate the efficacy and safety of Magnetic Seizure Therapy (MST) as an augmentation of antipsychotic medications for psychosis.
Official title: Accelerated 100Hz Magnetic Seizure Therapy for Psychotic Disorders
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-09-01
Completion Date
2025-12-30
Last Updated
2025-11-25
Healthy Volunteers
No
Conditions
Interventions
Magnetic seizure therapy by Magnetic stimulator
The seizure is induced by Magnetic stimulator of MagPro MST(XP),MagVenture A/S, Farum, Denmark. It is administered in combinations with antipsychotic medications
Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc)
It mainly includes second-generation antipsychotic medications, such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc, but except clozapine.
Locations (2)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China